Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?

Authors :: Avasarala J
Jain S
Urrea-Mendoza E
Source :: Journal of clinical pharmacology [J Clin Pharmacol] 2017 Nov; Vol. 57 (11), pp. 1415-1418. Date of Electronic Publication: 2017 May 25.
Publication Year :: 2017

Subjects :: Brain diagnostic imaging
Humans
Lymphopenia diagnostic imaging
Product Surveillance, Postmarketing
Fingolimod Hydrochloride adverse effects
Immunosuppressive Agents adverse effects
Lymphopenia chemically induced
Multiple Sclerosis, Relapsing-Remitting drug therapy

Full Text Access

Tools